-
digital.ahrq.gov/sites/default/files/docs/page/technology-to-enhance-communication-primary-care-and-health-counseling.pdf
July 02, 2015 - Zsolt Nagakaldi PhD
Consultant
Ardis.Olson@dartmouth.edu
Issues
Too much to address in health risk … • Too much advice
• Advice on empty ears
• Not tailored to patient/parent priorities
• Key health risks … easy clinician
determining priorities and agenda setting
• Dual function of screening for health risks … counseling for well visits ages 4-10
years
– Adolescent health visit counseling for multiple
risks … are
present
• Clinical tool
• Recruitment of population with specific risks for
participation in
-
psnet.ahrq.gov/training-catalog/niosh-training-nurses-shift-work-and-long-work-hours
NIOSH)
Event Description: This course presents scientific information about the risks … of shift work and long work hours and strategies to reduce these risks.
-
psnet.ahrq.gov/node/41784/psn-pdf
November 30, 2012 - procedural-safety-emergency-care-conceptual-model-and-recommendations
This commentary describes a conceptual model to address risks … procedural-safety-emergency-care-conceptual-model-and-recommendations
https://psnet.ahrq.gov/issue/2011-annual-benchmarking-report-malpractice-risks-emergency-medicine
-
www.qualitymeasures.ahrq.gov/sites/default/files/publications/files/caremgmt-brief.pdf
April 01, 2015 - • Use multiple metrics to
identify patients with
modifiable risks
• Develop risk-based
approaches … • Develop/refine tools for risk
stratification
• Develop predictive models to
support risk stratification … This requirement is particularly important for high-risk and/or high-cost
populations. … consequently at different stages of modifiable risk. … More work is needed to explore what constitutes
modifiable risks.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/publications/files/caremgmt-brief.pdf
April 01, 2015 - • Use multiple metrics to
identify patients with
modifiable risks
• Develop risk-based
approaches … • Develop/refine tools for risk
stratification
• Develop predictive models to
support risk stratification … This requirement is particularly important for high-risk and/or high-cost
populations. … consequently at different stages of modifiable risk. … More work is needed to explore what constitutes
modifiable risks.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T1-Talking_with_Residents_Final.pdf
October 01, 2016 - What are the risks—or harms—of antibiotics? … What is our nursing home doing to decrease the chance of these risks? … Decrease your risk of experiencing any harm, including C. diff infections and
antibiotic resistance … What are the risks—or harms—of antibiotics?
VI. … What is our nursing home doing to decrease the chance of these risks?
VII.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T1-Talking_with_Residents_Final.pdf
October 01, 2016 - What are the risks—or harms—of antibiotics? … What is our nursing home doing to decrease the chance of these risks? … Decrease your risk of experiencing any harm, including C. diff infections and
antibiotic resistance … What are the risks—or harms—of antibiotics?
VI. … What is our nursing home doing to decrease the chance of these risks?
VII.
-
psnet.ahrq.gov/node/37312/psn-pdf
January 05, 2012 - Delineation of risk through the exploration of a culture of
safety in community home health. … Delineation of Risk Through the Exploration of a Culture of Safety in
Community Home Health. … https://psnet.ahrq.gov/issue/delineation-risk-through-exploration-culture-safety-community-home-health … This study developed a chart review tool to better assess the risks facing community-based patients … and
discovered that the most frequent risks identified were mobility, fall prevention, and medication
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
August 08, 2018 - Category
Explanation
Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and
there are … in humans, but potential
benefits may warrant use of the drug in pregnant women despite potential
risks … in humans, but
potential benefits may warrant use of the drug in pregnant women despite
potential risks … based on adverse reaction data
from investigational or marketing experience, and the risks involved
-
psnet.ahrq.gov/issue/bad-hospital-design-making-us-sicker
March 30, 2016 - September 27, 2016
Hospitals target risks of color wristbands. … September 11, 2013
Scariest hospital risks. … July 28, 2013
Shifting the risks at night.
-
psnet.ahrq.gov/node/45682/psn-pdf
November 01, 2017 - changing-smart-pump-vendors-lessons-learned
Changes in processes, devices, and technologies can increase risk … psnet.ahrq.gov/issue/changing-smart-pump-vendors-lessons-learned
https://psnet.ahrq.gov/issue/benefits-and-risks-using-smart-pumps-reduce-medication-error-rates-systematic-review … https://psnet.ahrq.gov/issue/dont-underestimate-impact-change-risk-potential
https://psnet.ahrq.gov/ … issue/risks-implementation-and-use-smart-pumps-pediatric-intensive-care-unit-application-failure
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.368_slideshow.ppt
February 01, 2016 - PowerPoint Presentation
Spotlight
Robotic Surgery: Risks vs. … the robotic technology would allow for smaller incisions, better control of the instruments, lower risk … for infection, bleeding, and the risks of anesthesia
Additional risks are unique to robotic surgery
Potential … (2)
Notably, the energy source can cause burn injuries from the cautery device
There is a small risk … institutions should also submit local reports to the FDA
21
Appropriate Risk Disclosure to Patients
-
psnet.ahrq.gov/node/43011/psn-pdf
May 20, 2014 - issue/early-warnings-weak-signals-and-learning-healthcare-disasters
This commentary examines how minor risks … early-warnings-weak-signals-and-learning-healthcare-disasters
https://psnet.ahrq.gov/issue/managing-risks-organizational-accidents
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/tools/tool-2/share-tool2.pdf
April 01, 2014 - Communicate numbers in a way that your patient can understand
Numbers can be a big part of discussing risk … Tips
› Avoid descriptive terms (such as “low risk”). … side effects and of remaining free of side effects.
› Whenever possible, use absolute numbers—not relative … risks. … Numeracy skill and the communication, comprehension, and use of
risk-benefit information.